OptimizeRx Stock

OptimizeRx P/E 2024

OptimizeRx P/E

30.31

Ticker

OPRX

ISIN

US68401U2042

WKN

A2JL4Z

As of Nov 3, 2024, OptimizeRx's P/E ratio was 30.31, a -318.53% change from the -13.87 P/E ratio recorded in the previous year.

The OptimizeRx P/E history

OptimizeRx Aktienanalyse

What does OptimizeRx do?

The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering OptimizeRx's P/E Ratio

The Price to Earnings (P/E) Ratio of OptimizeRx is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing OptimizeRx's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of OptimizeRx is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in OptimizeRx’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about OptimizeRx stock

What is the price-to-earnings ratio of OptimizeRx?

The price-earnings ratio of OptimizeRx is currently 30.31.

How has the price-earnings ratio of OptimizeRx changed compared to last year?

The price-to-earnings ratio of OptimizeRx has increased by -318.53% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of OptimizeRx high compared to other companies?

Yes, the price-to-earnings ratio of OptimizeRx is high compared to other companies.

How does an increase in the price-earnings ratio of OptimizeRx affect the company?

An increase in the price-earnings ratio of OptimizeRx would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of OptimizeRx affect the company?

A decrease in the price-earnings ratio of OptimizeRx would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of OptimizeRx?

Some factors that influence the price-earnings ratio of OptimizeRx are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does OptimizeRx pay?

Over the past 12 months, OptimizeRx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OptimizeRx is expected to pay a dividend of 0 USD.

What is the dividend yield of OptimizeRx?

The current dividend yield of OptimizeRx is .

When does OptimizeRx pay dividends?

OptimizeRx pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OptimizeRx?

OptimizeRx paid dividends every year for the past 0 years.

What is the dividend of OptimizeRx?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OptimizeRx located?

OptimizeRx is assigned to the 'Health' sector.

Wann musste ich die Aktien von OptimizeRx kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OptimizeRx from 11/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did OptimizeRx pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of OptimizeRx in the year 2023?

In the year 2023, OptimizeRx distributed 0 USD as dividends.

In which currency does OptimizeRx pay out the dividend?

The dividends of OptimizeRx are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von OptimizeRx

Our stock analysis for OptimizeRx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OptimizeRx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.